Affiliations
AffiliationsItem in Clipboard
Smartphone-Enabled Health Coaching Intervention (iMOVE) to Promote Long-Term Maintenance of Physical Activity in Breast Cancer Survivors: Protocol for a Feasibility Pilot Randomized Controlled TrialPaul Ritvo et al. JMIR Res Protoc. 2017.
doi: 10.2196/resprot.6615. AffiliationsItem in Clipboard
AbstractBackground: Although physical activity has been shown to contribute to long-term disease control and health in breast cancer survivors, a majority of breast cancer survivors do not meet physical activity guidelines. Past research has focused on promoting physical activity components for short-term breast cancer survivor benefits, but insufficient attention has been devoted to long-term outcomes and sustained exercise adherence. We are assessing a health coach intervention (iMOVE) that uses mobile technology to increase and sustain physical activity maintenance in initially inactive breast cancer survivors.
Objective: This pilot randomized controlled trial (RCT) is an initial step in evaluating the iMOVE intervention and will inform development of a full-scale pragmatic RCT.
Methods: We will enroll 107 physically inactive breast cancer survivors and randomly assign them to intervention or control groups at the University Health Network, a tertiary cancer care center in Toronto, Canada. Participants will be women (age 18 to 74 years) stratified by age (55 years and older/younger than 55 years) and adjuvant hormone therapy (AHT) exposure (AHT vs no AHT) following breast cancer treatment with no metastases or recurrence who report less than 60 minutes of preplanned physical activity per week. Both intervention and control groups receive the 12-week physical activity program with weekly group sessions and an individualized, progressive, home-based exercise program. The intervention group will additionally receive (1) 10 telephone-based health coaching sessions, (2) smartphone with data plan, if needed, (3) supportive health tracking software (Connected Wellness, NexJ Health Inc), and (4) a wearable step-counting device linked to a smartphone program.
Results: We will be assessing recruitment rates; acceptability reflected in selective, semistructured interviews; and enrollment, retention, and adherence quantitative intervention markers as pilot outcome measures. The primary clinical outcome will be directly measured peak oxygen consumption. Secondary clinical outcomes include health-related quality of life and anthropometric measures. All outcome measures are administered at baseline, after exercise program (month 3), and 6 months after program (month 9).
Conclusions: This pilot RCT will inform full-scale RCT planning. We will assess pilot procedures and interventions and collect preliminary effect estimates.
Trial registration: ClinicalTrials.gov NCT02620735; https://clinicaltrials.gov/ct2/show/NCT02620735 (Archived by WebCite at https://clinicaltrials.gov/ct2/show/NCT02620735).
Keywords: RCT; breast neoplasm; exercise; health coaching; telehealth.
©Paul Ritvo, Maya Obadia, Daniel Santa Mina, Shabbir Alibhai, Catherine Sabiston, Paul Oh, Kristin Campbell, David McCready, Leslie Auger, Jennifer Michelle Jones. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 24.08.2017.
Conflict of interest statementConflicts of Interest: None declared.
FiguresFigure 1
Exercise volume progression.
Figure 1
Exercise volume progression.
Figure 1Exercise volume progression.
Similar articlesBuis LR, McCant FA, Gierisch JM, Bastian LA, Oddone EZ, Richardson CR, Kim HM, Evans R, Hooks G, Kadri R, White-Clark C, Damschroder LJ. Buis LR, et al. JMIR Res Protoc. 2019 Jan 29;8(1):e12526. doi: 10.2196/12526. JMIR Res Protoc. 2019. PMID: 30694208 Free PMC article.
Blair CK, Harding E, Wiggins C, Kang H, Schwartz M, Tarnower A, Du R, Kinney AY. Blair CK, et al. JMIR Cancer. 2021 Apr 13;7(2):e18819. doi: 10.2196/18819. JMIR Cancer. 2021. PMID: 33847588 Free PMC article.
Cheng KKF, Lim YTE, Koh ZM, Tam WWS. Cheng KKF, et al. Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD011152. doi: 10.1002/14651858.CD011152.pub2. Cochrane Database Syst Rev. 2017. PMID: 28836379 Free PMC article. Review.
Rogers LQ, McAuley E, Anton PM, Courneya KS, Vicari S, Hopkins-Price P, Verhulst S, Mocharnuk R, Hoelzer K. Rogers LQ, et al. Contemp Clin Trials. 2012 Jan;33(1):124-37. doi: 10.1016/j.cct.2011.09.004. Epub 2011 Sep 29. Contemp Clin Trials. 2012. PMID: 21983625 Free PMC article. Review.
Ganggayah MD, Dhillon SK, Islam T, Kalhor F, Chiang TC, Kalafi EY, Taib NA. Ganggayah MD, et al. Diagnostics (Basel). 2021 Aug 18;11(8):1492. doi: 10.3390/diagnostics11081492. Diagnostics (Basel). 2021. PMID: 34441426 Free PMC article.
Houghton LC, Howland RE, McDonald JA. Houghton LC, et al. Front Public Health. 2019 Nov 6;7:298. doi: 10.3389/fpubh.2019.00298. eCollection 2019. Front Public Health. 2019. PMID: 31781525 Free PMC article.
Dorri S, Asadi F, Olfatbakhsh A, Kazemi A. Dorri S, et al. Breast Cancer. 2020 Jan;27(1):25-46. doi: 10.1007/s12282-019-00982-3. Epub 2019 Jun 12. Breast Cancer. 2020. PMID: 31187411
Giunti G, Guisado Fernández E, Dorronzoro Zubiete E, Rivera Romero O. Giunti G, et al. JMIR Mhealth Uhealth. 2018 May 23;6(5):e10512. doi: 10.2196/10512. JMIR Mhealth Uhealth. 2018. PMID: 29792295 Free PMC article.
Caperchione CM, Sabiston CM, Stolp S, Bottorff JL, Campbell KL, Eves ND, Ellard SL, Gotay C, Sharp P, Pullen T, Fitzpatrick KM. Caperchione CM, et al. BMC Cancer. 2019 Mar 27;19(1):272. doi: 10.1186/s12885-019-5470-2. BMC Cancer. 2019. PMID: 30917793 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3